These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16002064)

  • 1. Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.
    Takeda H; Tsuji M; Ikoshi H; Yamada T; Masuya J; Iimori M; Matsumiya T
    Eur J Pharmacol; 2005 Jul; 518(1):30-9. PubMed ID: 16002064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor.
    Kogan HA; Marsden CA; Fone KC
    Eur J Pharmacol; 2002 Aug; 449(1-2):105-11. PubMed ID: 12163113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice.
    Ago Y; Harasawa T; Itoh S; Nakamura S; Baba A; Matsuda T
    Eur J Pharmacol; 2005 Sep; 520(1-3):86-90. PubMed ID: 16140294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT
    Takeda K; Tsuji M; Miyagawa K; Takeda H
    Neurosci Lett; 2017 Jan; 638():69-75. PubMed ID: 27939981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
    Lane EL; Cheetham S; Jenner P
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1124-31. PubMed ID: 15542624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
    Ago Y; Nakamura S; Baba A; Matsuda T
    Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA; Olabisi OA; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
    Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
    Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
    J Pharmacol Exp Ther; 2002 Dec; 303(3):952-8. PubMed ID: 12438514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.
    Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
    Neuropharmacology; 2004 Dec; 47(7):1053-61. PubMed ID: 15555639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No involvement of 5-HT(7) or 5-HT(1D) receptors in the (R)-8-OH-DPAT-induced depression of the monosynaptic reflex in spinalized rats.
    Honda M; Ono H
    Eur J Pharmacol; 2001 Sep; 427(2):125-9. PubMed ID: 11557264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor.
    Cheetham SC; Heal DJ
    Br J Pharmacol; 1993 Dec; 110(4):1621-9. PubMed ID: 8306109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.